Careers   Contact  

Find a Physician

Advanced Search


Baylor Scott & White Heart and Vascular Hospital continues to be a leader in cardiovascular care through their involvement in innovative research to drive the future of cardiovascular medicine.
Published with Permission, Baylor Scott & White Health

Dan M. Meyer, MD

Medical leader presents updates in cardiorenal medicine

Peter McCullough, MD, MPH, FACC, FACP, FAHA, FCCP, FNKF, FNLA, FCRSA, medical director for Cardiovascular Research and Education – Baylor Scott & White Heart and Vascular Institute, presented a keynote address at the 17th Annual World Congress Insulin Resistance Diabetes and Cardiovascular Disease held in Las Angeles, CA. Dr. McCullough also represented Baylor Scott & White Heart and Vascular Hospital and Baylor University Medical Center as he presented Diabetes and the Cardiorenal Syndrome. His paper, "Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis and Treatment Strategies, A Scientific Statement from the American Heart Association," was published in the AHA's Circulation, and is an updated summary of new knowledge in the field of cardiorenal medicine and specifically addresses the issue of combined heart and kidney failure.

Dan M. Meyer, MD

Baylor University Medical Center chosen as one of six US sites for trial of new total artificial heart

Many patients with advanced heart failure can be managed by a left ventricular assist device (LVAD). But there are some patients who are not candidates for an LVAD because they have biventricular failure. Baylor Dallas has been chosen as one of six clinical trial sites for the world’s most advanced total artificial heart. “No major changes have occurred in the field of total artificial heart in decades, so we are very excited to be able to offer access to participation in a clinical trial for this innovative pump to our patients who qualify,” says Dan M. Meyer, MD, surgical chief of heart transplant and mechanical circulatory support at Baylor Dallas. Tell me more.


Cara East, MD, FACP, FAPCR

Congratulations to Cara East, MD, FACP, FAPCR, on her new book titled Developing a Successful Clinical Research Program based on her experience leading the Soltero Cardiovascular Research. Beth Soltero hosted a book signing at the Soltero office on Oct. 19, 2018. Patients involved in some of her clinical trials, as well as fellow providers and family friends attended the event. Learn more about current clinical trials


Medical Director Appointed Associate Editor of an ACC Journal

Paul Grayburn, MD, FACC

Paul Grayburn, MD, FACC, Medical Director, Non-Invasive Cardiology – Baylor Scott & White Heart and Vascular Hospital – Dallas; Medical Director, Cardiology Research and Education – Baylor University Medical Center, was recently appointed by the American College of Cardiology (ACC) as an associate editor for the Journal of the American College of Cardiology: Cardiovascular Imaging. This prestigious appointment is the latest in Dr. Grayburn’s list of journal-related involvement as he is an associate editor for American Journal of Cardiology as well as Structural Heart: Journal of the Heart Team.

Dr. Grayburn has published more than 400 manuscripts or book chapters in peer-reviewed journals. He has served in leadership roles in several multicenter trials (BEST, STICH, EVEREST II, COAPT, CTSN, Apollo) and directs an echocardiographic core laboratory for clinical trials in valvular heart disease. Dr. Grayburn is also a Clinical Professor of Medicine at Texas A&M University.

New Trial Reduces Rate of Kidney Damage in Patients with Diabetes

PARADIGM-HF trial is shown to help reduce the rate of kidney function loss up to 50 percent more than conventional treatment in patients with diabetes. Milton Packer, MD, reviews the study and reports on results.

Landmark Research Program Advances Precision Medicine for All of Us

Baylor Scott & White Heart and Vascular Hospital is one of three Baylor Scott & White Health locations currently serving as a study site for system's participation in a landmark precision medicine study – the All of Us Research Program. All of Us is the largest study ever executed in the United States by the National Institutes of Health (NIH), with a goal of enrolling 1 million participants across the country.

Baylor Scott & White is currently the only healthcare provider in Texas enrolling participants in the study and will receive a total of $14 million in funding from NIH over five years. The system is collaborating through a consortium that includes Baylor Scott & White, Henry Ford Health System in Detroit, Essentia Health headquartered in Minnesota, Spectrum Health in Michigan and University of Massachusetts Medical School.

Milton Packer, MD

Did I Actually Win an Award — For Journalism?

Milton Packer reflects on the impact and future of his blog

Dr. Packer won a national award in specialized journalism — the Jesse H. Neal Award — in the category of "Best Commentary/Blog." The Neal Awards are considered the "Pulitzer Prize" of the business press. Established in 1955, the Neal Awards strive to recognize journalists that "act as the conscience of the fields they serve."

Congratulations to Baylor Scott & White Heart and Vascular Institute Research Team for Grant Awarded

Team recognized for award; project lead Tecson announced

March 20, 2017 – Baylor Scott & White Heart and Vascular Institute has executed a contract for a major research grant or nearly one-quarter of a million dollars under an investigator initiated original research submission to Amgen, Inc. The proposal prepared is titled, Therapeutic Intensity of Lipid Lowering Therapy on Recurrent Cardiovascular Events. The project will harness the power of the data infrastructure to evaluate the pharmaco-epidemiology of cholesterol lowering medications in patients with recurrent heart attacks. Stated Peter McCullough, MD, MPH, FACC, FACP, FAHA, FCCP, FNKF, FNLA, who designed the study, "This is important work given the new genre of super-powerful cholesterol lowering agents that are given via injections but at high costs. Please join me in congratulating Kristen Tecson, PhD, who will lead this project. I want to recognize Puja Garg, PhD, and Anu Vasudevan, PhD, who have worked administratively during the award process and will be integral to the research team as this project moves forward." Baylor Scott & White Heart and Vascular Hospital team congratulates the entire research team on this announcement.

American College of Cardiology Honors Dr. William C. Roberts

William C. Roberts, MD

William C. Roberts, MD, honored by American College of Cardiology with a Lifetime Achievement Award, prestigious recognition from the American College of Cardiology on Monday, April 4, 2016, in Chicago.
read more

For a listing of Dr. Roberts' books:

1. Roberts WC, editor in chief. From-the-Editor Columns Published in The American Journal of Cardiology 1982-2015. Dallas: Baylor Scott & White Health 2016:623.
2. Roberts WC, editor in chief, Interviews Published in The American Journal of Cardiology 1982 – 2015, Volume 1:A-K. Dallas: Baylor Scott & White Health 2016:684.
3. Roberts WC, editor in chief. Interviews Published in The American Journal of Cardiology 1982 – 2015, Volume 2: L-Z. Dallas: Baylor Scott & White Health 2016:571.
4. Roberts WC, interviewer and Editor. Collected Interviews of Baylor University Medical Center Physicians and Administrators Published in Baylor University Medical Center Proceedings 1995 – 2015, Dallas: Baylor Scott & White Health 2015:951.
5. Roberts WC, editor in chief. Facts and Ideas from Anywhere: From-the-Editor Columns Published in Baylor University Medical Center Proceedings 2011 – 2015, Dallas: Baylor Scott & White Health 2015:509.
6. Roberts WC, interviewer and editor. Collected Interviews of Some Visiting Professors

Baylor Heart and Vascular welcomes Dr. Packer

Milton Packer, MD

DALLAS December 3, 2015 – Baylor University Medical Center at Dallas announces the appointment of Milton Packer, MD, as the new Distinguished Scholar in Cardiovascular Science. Dr. Packer's recent study findings now published in latest New England Journal of Medicine.
read the release

Dr. Packer's Video Interview

Research Team Publishes Findings on New Heart Failure Drugs That Prolong Patient's Lives

Dr. Packer, Distinguished Scholar, can be reached through Baylor Heart and Vascular Institute at 214-820-7500

Baylor Scott & White Heart and Vascular Hospital Firsts

In addition to opening the first heart-specialty hospital in North Texas, Baylor Scott & White Heart and Vascular Hospital has paved the way in heart and vascular care with breakthrough techniques. Just look at these North Texas firsts at Baylor Scott & White Heart and Vascular Hospital:

  • First coronary balloon angioplasty
  • First vascular balloon angioplasty
  • First abdominal aortic aneurysm surgery
  • First carotid endarterectomy for stroke prevention
  • First arterial stent
  • First vascular venous stent
  • First implantable defibrillator
  • First atherectomy
  • First coronary atherectomy
  • First combined heart-lung and heart transplantation Domino in Texas
  • First combined heart/kidney transplant in North Texas and fifth in the world
  • First implant of St. Jude stentless valve in the United States after FDA approval
  • First Gamma Radiation seed implant for coronary stent restenosis
  • First percutaneous transmyocardial revascularization
  • First AACVPR-certified cardiac rehabilitation program
  • First modular aortic endovascular stent graft
  • First biventricular pacemaker defibrillator for heart failure
  • First three-dimensional computer mapping system for arrhythmia diagnosis and management
  • First non-surgical vascular bypass (transjugular intrahepatic portosystematic shunt)
  • First carotid stent
  • First arterial catheterization
  • First modular aortic stent graft

 Find A Physician

 Download the App

 Let's Chat

 HeartSpeak Podcast